News
Shares of Pfizer Inc. PFE rallied 3.63% to $25.14 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and the ...
Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...
These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.
Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...
Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.
Explore more
In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
New York City’s housing shortage may find an unlikely hero in its glut of underused office buildings, according to Brad ...
A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results